Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and gnrh antagonist cotreatment

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4186-4192

  Beckers, Nicole G M ^a   Macklon, Nicholas S ^a   Eijkemans, Marinus J ^a   Ludwig, Michael ^b   Felberbaum, Ricardo E ^b   Diedrich, Klaus ^b   Bustion, Shelly ^c   Loumaye, Ernest ^c   Fauser, Bart C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b University Clinic   (Germany)

^c Serono International SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INJECTION; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MALE; OOCYTE MATURATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZATION;

ADULT; AREA UNDER CURVE; CHORIONIC GONADOTROPIN; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEAL PHASE; LUTEINIZING HORMONE; OOCYTES; OVARY; PROGESTERONE; RECOMBINANT PROTEINS; STIMULATION, CHEMICAL;

EID: 0141606263     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021953     Document Type: Article

References (37)

1. Smitz J, Ron-El R, Tarlatzis BC 1992 The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres. Hum Reprod 7(Suppl 1):49-66
2. Soliman S, Daya S, Collins J, Hughes EG 1994 The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 61:1068-1076
3. Beckers NG, Laven JS, Eijkemans MJ, Fauser BC 2000 Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in vitro fertilization. Hum Reprod 15:43-49
4. Smitz J, Erard P, Camus M, Devroey P, Tournaye H, Wisanto A, Van Steirteghem AC 1992 Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Hum Reprod 7:1225-1229
5. Donderwinkel PF, Schoot DC, Pache TD, de Jong FH, Hop WC, Fauser BC 1993 Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist. Hum Reprod 8:2027-2032
6. Messinis IE, Templeton AA 1987 Disparate effects of endogenous and exogenous oestradiol on luteal phase function in women. J Reprod Fertil 79:549-554
7. Hohmann FP, Laven JS, de Jong FH, Eijkemans MJ, Fauser BC 2001 Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. Hum Reprod 16:846-854
8. Garcia J, Jones GS, Acosta AA, Wright Jr GL 1981 Corpus luteum function after follicle aspiration for oocyte retrieval. Fertil Steril 36:565-572
9. Vargyas J, Kletzky O, Marrs RP 1986 The effect of laparoscopic follicular aspiration on ovarian steroidogenesis during the early preimplantation period. Fertil Steril 45:221-225
10. Smitz J, Devroey P, Van Steirteghem AC 1990 Endocrinology in luteal phase and implantation. Br Med Bull 46:709-719
11. Fauser BC, Devroey P 2003 Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab 14:236-242
12. Sungurtekin U, Jansen RP 1995 Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone-agonist leuprolide acetate. Fertil Steril 63:663-665
13. Ditkoff EC, Cassidenti DL, Paulson RJ, Sauer MV, Paul WL, Rivier J, Yen SS, Lobo RA 1991 The gonadotropin-releasing hormone antagonist (Na1-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. Am J Obstet Gynecol 165:1811-1817
14. Fattinger KE, Verotta D, Porchet HC, Munafo A, Le Cotonnec JY, Sheiner LB 1996 Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide. Am J Physiol 271:E775-E787
15. Oberye JJ, Mannaerts BM, Huisman JA, Timmer CJ 1999 Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers. Fertil Steril 72:1006-1012
16. Elter K, Nelson LR 2001 Use of third generation gonadotropin-releasing hormone antagonists in in vitro fertilization-embryo transfer: a review. Obstet Gynecol Surv 56:576-588
17. Ragni G, Vegetti W, Baroni E, Colombo M, Arnoldi M, Lombroso G, Crosignani PG 2001 Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist. Hum Reprod 16:2258-2262
18. Albano C, Smitz J, Toumaye H, Riethmuller-Winzen H, Van Steirteghem A, Devroey P 1999 Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in vitro fertilization/intracytoplasmic sperm injection cycles. Hum Reprod 14:1426-1430
19. de Jong D, Macklon NS, Fauser BC 2000 A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix. Fertil Steril 73:1051-1054
20. Tavaniotou A, Albano C, Smitz J, Devroey P 2002 Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist. Fertil Steril 77:733-737
21. Gonen Y, Balakier H, Powell W, Casper RF 1990 Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 71:918-922
22. Emperaire JC, Ruffie A 1991 Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome. Hum Reprod 6:506-510
23. Fauser BC, de Jong D, Olivennes F, Wrambsi H, Tay C, Itskovitz-Eldor J, van Hooren HG 2002 Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after co-treatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 87:709-715
24. The European Recombinant LH Study Group 2001 Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 86:2607-2618
25. Cahill DJ, Wardle PG, Harlow CR, Hunt LP, Hull MG 2000 Expected contribution to serum oestradiol from individual ovarian follicles in unstimulated cycles Hum Reprod 15:1909-1912
26. The European Recombinant Human Chorionic Gonadotrophin Study Group 2000 Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment - recombinant HCG versus urinary HCG. Hum Reprod 15:1446-1451
27. Chang P, Kenley S, Burns T, Denton G, Currie K, DeVane G, O'Dea L 2001 Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril 76:67-74
28. Hohmann FP, Macklon NS, Fauser BC 2003 A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist co-treatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab 88:166-173
29. Shoham Z, Schacter M, Loumaye E, Weissman A, MacNamee M, Insler V 1995 The luteinizing hormone surge - the final stage in ovulation induction: modern aspects of ovulation triggering. Fertil Steril 64:237-251
30. McCracken JA, Custer EE, Lamsa JC 1999 Luteolysis: a neuroendocrine-mediated event. Physiol Rev 79:263-323
31. Van de Wiele RL, Bogumil J, Dyrenfurth I, Ferin M, Jewelewicz R, Warren M, Rizkallah T, Mikhail G 1970 Mechanisms regulating the menstrual cycle in women. Recent Prog Horm Res 26:63-103
32. Filicori M, Butler JP, Crowley Jr WF 1984 Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest 73:1638-1647
33. Collins RL, Sopelak VM, Williams RF, Hodgen GD 1986 Prevention of gonadotropin-releasing hormone antagonist induced luteal regression by concurrent exogenous pulsatile gonadotropin administration in monkeys. Fertil Steril 46:945-953
34. Duffy DM, Stewart DR, Stouffer RL 1999 Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys. J Clin Endocrinol Metab 84:342-349
35. Weissman A, Loumaye E, Shoham Z 1996 Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation. Hum Reprod 11:943-949
36. Junca AM, Mandelbaum J, Belaisch-Allart J, Salat-Baroux J, Plachot M, Antoine JM, Mayenga JM, Delafontaine M, Cohen J 1995 Oocyte maturity and quality: value of intracytoplasmic sperm injection. Fertility of microinjected oocytes after in vitro maturation. Contracept Fertil Sex 23:463-465
37. Chandrasekher YA, Hutchison JS, Zelinski-Wooten MB, Hess DL, Wolf DP, Stouffer RL 1994 Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge. J Clin Endocrinol Metab 79:298-306